There is an established process—it even has an acronym—and decision-makers are boasting about its importance, enduring effectiveness, and operation that is entirely consistent with the existing legal framework for HTA decision-making. Stakeholders should demand its more comprehensive application. …
Why not use the rHTA process that's 'consistent' with existing framework?
April 8, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Funding for new chemotherapy-free immunotherapy combination for follicular lymphoma
August 3, 2026 - - Latest News -
The HTA Review and the 'Abilene paradox' - when everyone argues for reforms that nobody wants
August 3, 2026 - - Latest News -
First new brain cancer treatment listed on PBS after more than 20 years
August 3, 2026 - - Latest News -
Listing offers treatment option for Australians with tumour induced osteomalacia
August 3, 2026 - - Latest News -
The 'Dispatched' Week in Review' Podcast - 31 July
July 31, 2026 - - Podcast -
New partnership aims to create national blueprint for earlier Alzheimer’s diagnosis and care
July 31, 2026 - - Latest News -
Industry associations still resisting non-disclosure agreements for negotiation
July 31, 2026 - - Latest News